Submit Manuscript    >>    Login | Register

AF Literature Database


Search Knowledgebase by



Author last name starts with
B. Weijs(4)Ayman A. Hussein, MD(3)Asirvatham Samuel J SJ(3)
Alan S. Go, MD(3)Charlotte Eitel, MD(3)Badger Troy J TJ(2)
Charlotte Eitel(2)Blanke Philipp P(2)Anné Wim W(2)
Chamberlain AM(2)Berenfeld Omer O(2)Caputo M(2)
Chao TF(2)Chen Peng-Sheng PS(2)Albert Nancy M NM(2)
Andrade JG(2)Akira Fukui, MD(2)Ajay K Jain(2)
Cook G Elliott GE(2)Botto GL(2)Bokeriia L A LA(2)
Casella M(2)Antonio Hernández-Madrid(2)Christian Sohns(2)
Bengt Zöller(2)Andreou Andreas Yiangou AY(1)Boccuzzi Stephen J SJ(1)
Coronel Ruben R(1)Albers Gregory W GW(1)Cappato Riccardo R(1)
Bugnicourt Jean-Marc JM(1)Brenyo AJ(1)Ariel Dogliotti(1)
Candeias Rui R(1)Bolderman Robert W RW(1)Chang Jen-Ping JP(1)
Bouzas-Mosquera Alberto A(1)Choi Jong-Il JI(1)Burashnikov A(1)
Alina Scridon(1)Anousheh Ramtin R(1)Bellamy L L(1)
Callanan Deborah D(1)Calvo Naiara N(1)Brown Aaron Michael AM(1)
Angelo Auricchio(1)Baker William L WL(1)Bockeria Leo L(1)
Canabal Berlanga A A(1)Abe Hidetoshi H(1)


Literature Related to Hugo A. Katus, MD [Author]
1
  • Connexin 43 gene therapy prevents persistent atrial fibrillation in a porcine model


    Authors : Bikou O; Thomas D; Trappe K; Lugenbiel P; Kelemen K; Koch M; Soucek R; Voss F; Becker R; Katus HA;

    Affiliations : Department of Cardiology, Medical University Hospital, Im Neuenheimer Feld 410, Heidelberg D-69120, Germany. Tel: +49 6221 568855; fax: +49 6221 565514, Email: olympia.bikou@med.uni-heidelberg.de; dierk.thomas@med.uni-heidelberg.de

    Journal : Eurpopace   (2011 )

    Related Links: Pubmed | Publisher website


  • Biomarkers in relation to the effects of ticagrelor in comparison with clopidogrel in non-ST-elevation acute coronary syndrome patients managed with or without in-hospital revascularization: a substudy from the Prospective Randomized Platelet Inhibition a


    Authors : Daniel Lindholm, MD; Agneta Siegbahn, MD, PhD; Lisa Wernroth, MSc; Richard C. Becker, MD; Christopher P. Cannon, MD; Jan H. Cornel, MD, PhD; Anders Himmelmann, MD, PhD; Evangelos Giannitsis, MD; Robert A. Harrington, MD; Claes Held, MD, PhD; Steen Husted, MD, DSc; Hugo A. Katus, MD; Kenneth W. Mahaffey, MD; Ph. Gabriel Steg, MD; Robert F. Storey, MD, DM; Stefan K. James, MD, PhD;

    Affiliations : Department of Medical Sciences, Cardiology and Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden (L.W., D.L., L.W., C.H., S.K.J.); Department of Medical Sciences, Clinical Chemistry and Uppsala Clinical Research Center Uppsala University, Uppsala, Sweden (A.S.); Division of Cardiovascular Health and Disease, Heart, Lung and Vascular Institute, Academic Health Center, Cincinnati, OH (R.C.B.); Department of Medicine, Stanford University, Stanford, CA (R.A.H., K.W.M.); TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, Boston, MA (C.P.C.); Department of Cardiology, Medisch Centrum Alkmaar, Alkmaar, Netherlands (J.H.C.); AstraZeneca Research and Development, Mölndal, Sweden (A.H.); Medizinische Klinik, Universitätsklinikum Heidelberg, Heidelberg, Germany (E.G., H.A.K.); Medical Department, Hospital Unit West, Herning/Holstbro, Denmark (S.H.); INSERM-Unité 698, Paris, France; Assistance Publique-Hôpitaux de Paris, Département Hospitalo-Universitaire FIRE, Hôpital Bichat, Paris, France; Université Paris-Diderot, Sorbonne-Paris Cité, Paris, France; NHLI Imperial College, ICMS, Royal Brompton Hospital, London, UK (P.G.S.); and Department of Cardiovascular Science, University of Sheffield, Sheffield, UK (R.F.S.).

    Journal : N/A   (2014)

    Related Links: Pubmed | Publisher website



Biosense Webster
event date
Introduction to AFib
Ablation Specialist

View Ablation Specialists